95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-17.85%
Negative revenue growth while FNV stands at 3.53%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-10.34%
Negative gross profit growth while FNV is at 20.67%. Joel Greenblatt would examine cost competitiveness or demand decline.
-14.45%
Negative EBIT growth while FNV is at 27.20%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-14.45%
Negative operating income growth while FNV is at 26.47%. Joel Greenblatt would press for urgent turnaround measures.
149.47%
Net income growth above 1.5x FNV's 48.51%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
148.39%
EPS growth above 1.5x FNV's 52.17%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
148.39%
Diluted EPS growth above 1.5x FNV's 52.17%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while FNV stands at 11.95%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-24.07%
Negative OCF growth while FNV is at 8.87%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-23.82%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
105.28%
10Y revenue/share CAGR at 50-75% of FNV's 208.27%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-22.48%
Negative 5Y CAGR while FNV stands at 25.55%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
27.89%
3Y revenue/share CAGR at 75-90% of FNV's 33.45%. Bill Ackman would expect new product strategies to close the gap.
91.05%
10Y OCF/share CAGR under 50% of FNV's 574.83%. Michael Burry would worry about a persistent underperformance in cash creation.
-39.41%
Negative 5Y OCF/share CAGR while FNV is at 41.84%. Joel Greenblatt would question the firm’s operational model or cost structure.
17.79%
3Y OCF/share CAGR under 50% of FNV's 66.79%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
23.01%
Below 50% of FNV's 509.35%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-59.13%
Negative 5Y net income/share CAGR while FNV is 44.01%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
15.47%
Below 50% of FNV's 183.25%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
205.07%
10Y equity/share CAGR above 1.5x FNV's 50.41%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
22.24%
5Y equity/share CAGR 1.25-1.5x FNV's 18.14%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
-6.81%
Negative 3Y equity/share growth while FNV is at 19.33%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-61.08%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-0.80%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.53%
Positive BV/share change while FNV is negative. John Neff sees a clear edge over a competitor losing equity.
-13.90%
We’re deleveraging while FNV stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
11.86%
We expand SG&A while FNV cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.